An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use.

Multiplex immunofluorescence (mIF) allows simultaneous antibody-based detection and quantification of the expression of up to six markers, plus a nuclear counterstain, on a single tissue section. Recent studies have shown the potential for mIF to advance our understanding of complex disease processes, including cancer. It is important that the technique be standardised and validated to facilitate its transition into clinical use. Traditional approaches to mIF rely on manual processing of sections, which is time-consuming and a source of significant variation between samples/individuals. Here we determined if an automated diagnostic tissue stainer could be used for mIF incorporating tyramide signal amplification (TSA), and how the final image quality compared with sections stained semi-automatically or manually. Using tissue microarrays of fixed human breast tumour sections, we observed comparable antibody labelling between the diagnostic autostainer and manual technique. The diagnostic autostainer produced higher signal intensity with similar spectral unmixing efficiency. We also found that microwave treatment for antibody stripping during TSA labelling could be replaced by the heating option incorporated within the diagnostic-use autostainer. These data show that diagnostic autostainers used for traditional immunohistochemistry protocols can be readily adapted to achieve rapid preparation of high-quality sections using a TSA method for clinical mIF.

[1]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  I. Dawson,et al.  Immunochemical studies of the endocrine cells of the gastrointestinal tract. II An immunoperoxide technique for the localization of secretin containing cells in human duodenum. , 1975, Journal of clinical pathology.

[3]  Michael Neuberger,et al.  Multispectral Imaging of T and B Cells in Murine Spleen and Tumor , 2016, The Journal of Immunology.

[4]  P. Tan,et al.  Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer , 2017, Breast Cancer Research and Treatment.

[5]  Haidong Dong,et al.  Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.

[6]  Wei Huang,et al.  Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. , 2014, Human pathology.

[7]  A. Bertoletti,et al.  Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. , 2009, Gastroenterology.

[8]  J. Madore,et al.  Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome , 2016, Histopathology.

[9]  Pierre Hainaut,et al.  Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy. , 2013, Current opinion in oncology.

[10]  G. B. Pierce,et al.  ENZYME-LABELED ANTIBODIES: PREPARATION AND APPLICATION FOR THE LOCALIZATION OF ANTIGENS , 1966, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  H. Kohrt,et al.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients , 2014, Nature.

[12]  Y. Sun,et al.  High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment , 2014, British Journal of Cancer.

[13]  K. Shirouzu,et al.  FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis , 2013, Molecular and clinical oncology.

[14]  Stephen M. Douglass,et al.  Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12 , 2014, The Journal of pathology.

[15]  S. Rosenberg,et al.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.

[16]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[17]  G. Botti,et al.  Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients , 2017, International journal of molecular sciences.

[18]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[19]  A. Tzankov,et al.  Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas , 2010, Disease markers.

[20]  Chichung Wang,et al.  Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. , 2014, Methods.

[21]  T. Chung,et al.  Assay Format as a Critical Success Factor for Identification of Novel Inhibitor Chemotypes of Tissue-Nonspecific Alkaline Phosphatase from High-Throughput Screening , 2010, Molecules.

[22]  H. Idikio Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains. , 2009, International journal of clinical and experimental pathology.

[23]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[24]  Hailing Lu FOXP3 expression and prognosis: role of both the tumor and T cells. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Patrice Ravel,et al.  PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.

[26]  R. Kalluri,et al.  Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis , 2015, Nature Medicine.